Acuña Pais Beatriz, Casais Rocío, Lugo Julio, Piñón Miguel Á, Legarra Juan J
Cardiovascular Surgery Service, Álvaro Cunqueiro Hospital, Carretera de Clara Campoamor, Vigo, Spain.
J Cardiovasc Thorac Res. 2023;15(2):121-126. doi: 10.34172/jcvtr.2023.31597. Epub 2023 Jun 29.
Renal cell carcinoma represents 3% of solid tumors. In 4-10% of patients, venous tumor thrombosis is present, and 1% reaches the right atrium. Other tumors can be associated with tumor thrombosis. The natural history of venous tumor thrombosis implies a mean survival of 5 months. Between 2001 and 2021, 4 patients underwent resection of tumor thrombi into the right atrium, requiring cardiopulmonary bypass. None of the patients died within 30 days postoperatively. Mean follow-up time was 30.9 months (2.4- 96.1). Two patients are still alive and two died due to disease progression. Died patient's follow-up was 7.5 and 17.4 months, surpassing life expectancy of those without surgery. We present a series of patients who underwent lumpectomy and IVC thrombectomy. IVC tumor thrombosis has an ominous prognosis, however surgical treatment has an important role by improving the survival of these patients. The multidisciplinary approach is necessary to obtain good postoperative results.
肾细胞癌占实体肿瘤的3%。4%至10%的患者存在静脉肿瘤血栓形成，1%的患者血栓可延伸至右心房。其他肿瘤也可能与肿瘤血栓形成相关。静脉肿瘤血栓形成的自然病程意味着平均生存期为5个月。2001年至2021年期间，4例患者接受了右心房肿瘤血栓切除术，手术需要体外循环。所有患者术后30天内均未死亡。平均随访时间为30.9个月（2.4至96.1个月）。2例患者仍存活，2例因疾病进展死亡。死亡患者的随访时间分别为7.5个月和17.4个月，超过了未接受手术患者的预期寿命。我们报告了一系列接受肿块切除术和下腔静脉血栓切除术的患者。下腔静脉肿瘤血栓形成预后不佳，然而手术治疗通过提高这些患者的生存率发挥着重要作用。多学科方法对于获得良好的术后结果是必要的。
